SS
AXSM icon

SBI Securities’s Axsome Therapeutics AXSM Stock Holding History

SBI Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.79K Buy
40
+15
+60% +$3.25K ﹤0.01% 1849
2026
Q1 		$4.23K Sell
25
-2
-7% -$345 ﹤0.01% 2104
2025
Q4 		$4.93K Buy
27
+6
+29% +$838 ﹤0.01% 2032
2025
Q3 		$2.55K Buy
21
+2
+11% +$225 ﹤0.01% 2328
2025
Q2 		$1.98K Sell
19
-10
-34% -$1.06K ﹤0.01% 2385
2025
Q1 		$3.38K Sell
29
-30
-51% -$3.42K ﹤0.01% 2062
2024
Q4 		$4.99K Buy
+59
New +$5.43K ﹤0.01% 1922

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SBI Securities's AXSM Position: Q2 2026 in Review

SBI Securities increased its Axsome Therapeutics (AXSM) stake by 60% in Q2 2026, buying an estimated $3.25K and bringing the position to 40 shares worth $9.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

SBI Securities first reported a position in AXSM in Q4 2024 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • SBI Securities held 40 shares of Axsome Therapeutics worth $9.79K as of Q2 2026.
  • SBI Securities bought 15 Axsome Therapeutics shares in Q2 2026, an estimated $3.25K.
  • Axsome Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1849 holding.
  • SBI Securities first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.